Completed
Celgosivir as a Treatment Against Dengue
NCT01619969
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +8 more
- Locations
-
- Singapore General Hospital Singapore
Clinical trial condition
Dengue Fever
Explore clinical trials studying Dengue Fever. Study availability and eligibility vary by location and protocol.
85 public trials
6 recruiting studies
Dengue Fever trial results
Completed
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy Adults
NCT00831012
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +9 more
- Locations
-
- Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States
NCT01917422
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +8 more
- Locations
-
- Kaoshing Medical University Chung-Ho Memorial Hospital Kaoshiung, Taiwan
NCT01064141
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +10 more
- Locations
-
- San Pablo, Philippines
Completed
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults
NCT00270699
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +9 more
- Locations
-
- Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States
NCT00920517
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +8 more
- Locations
-
- Center for Immunization Research Baltimore, Maryland, United States
NCT00946218
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +8 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
- Hospital Nacional de Ninos Benjamin Bloom San Salvador, El Salvador
NCT01443247
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +8 more
- Locations
-
- Post Graduate Institute of Medical Education and Research , Chandigarh , India Chandigarh, India
Completed
Study of HBV-001 D1 in Healthy Adults
NCT00936429
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +9 more
- Locations
-
- Saint Louis University St Louis, Missouri, United States
Completed
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults
NCT00094705
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +9 more
- Locations
-
- Johns Hopkins School of Public Health Baltimore, Maryland, United States